Skip to content

Drug interactions

Siponimod + Tagraxofusp

Severity: Moderate

Siponimod and Tagraxofusp: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tagraxofusp is used in blastic plasmacytoid dendritic cell neoplasm and can cause cytopenias and capillary leak syndrome. Siponimod lowers lymphocytes, so combined use may add to infection risk.

What this interaction means in plain words

Siponimod and Tagraxofusp can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Siponimod belongs to Central Nervous System; Tagraxofusp belongs to Oncology.

Evidence level: Low

Why it happens

Additive effects on immunity: cytotoxic CD123-directed myelosuppression plus S1P receptor-mediated lymphocyte sequestration.

What to do

Monitor blood counts and for infection during therapy. Reassess whether siponimod should continue during treatment of the malignancy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Siponimod and Tagraxofusp, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Siponimod with Tagraxofusp?

MediHelp rates the interaction as moderate. Siponimod and Tagraxofusp can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tagraxofusp is used in blastic plasmacytoid dendritic cell neoplasm and can cause cytopenias and capillary leak syndrome. Siponimod lowers lymphocytes, so combined use may add to infection risk.

How serious is the interaction between Siponimod and Tagraxofusp?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and for infection during therapy. Reassess whether siponimod should continue during treatment of the malignancy.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in